Explore

Trendline Trendline
Eli Lilly Acquires Three Vaccine Developers to Enhance Infectious Disease Prevention

Eli Lilly Acquires Three Vaccine Developers to Enhance Infectious Disease Prevention

Eli Lilly Acquires Three Vaccine Developers to Enhance Infectious Disease Prevention
Trendline Trendline
Eli Lilly Reenters Infectious Disease Market with $3.8 Billion Acquisitions

Eli Lilly Reenters Infectious Disease Market with $3.8 Billion Acquisitions

Eli Lilly Reenters Infectious Disease Market with $3.8 Billion Acquisitions
Trendline Trendline
Eli Lilly Acquires Three Vaccine Developers to Boost Infectious Disease Prevention

Eli Lilly Acquires Three Vaccine Developers to Boost Infectious Disease Prevention

Eli Lilly Acquires Three Vaccine Developers to Boost Infectious Disease Prevention
Trendline Trendline
Eli Lilly Acquires Three Companies to Enhance Infectious Disease Portfolio

Eli Lilly Acquires Three Companies to Enhance Infectious Disease Portfolio

Eli Lilly Acquires Three Companies to Enhance Infectious Disease Portfolio
Reuters Reuters
US FDA advisers to weigh updating 2026-27 COVID vaccines to target XFG variant

US FDA advisers to weigh updating 2026-27 COVID vaccines to target XFG variant

May 26 (Reuters) - Advisers to the U.S. Food and Drug Administration will discuss whether COVID-19 vaccines should be updated to target the latest circulating XFG subvariant for the 2026-27 immunization campaign, according to documents filed on Tuesday.
Trendline Trendline
S Global Announces Leadership Change and Strategic Realignment in Data and Technology

S Global Announces Leadership Change and Strategic Realignment in Data and Technology

S Global Announces Leadership Change and Strategic Realignment in Data and Technology
TheStreet TheStreet
Here’s where the next market upside comes from

Here’s where the next market upside comes from

Transcript: Caroline WoodsJoining me now, Ross Gerber, CEO of Gerber Kawasaki. Ross, great to have you back. Thanks so much for being here. Yeah. Ross GerberGreat to be back. Thanks for having me. Caroline WoodsSo we're kicking off this holiday shortened week with the S&P and Nasdaq both ...
Trendline Trendline
Eli Lilly Acquires Three Biotech Firms for $3.8 Billion to Boost Vaccine Development

Eli Lilly Acquires Three Biotech Firms for $3.8 Billion to Boost Vaccine Development

Eli Lilly Acquires Three Biotech Firms for $3.8 Billion to Boost Vaccine Development
Trendline Trendline
CordenPharma Acquires AmbioPharm to Enhance U.S. Peptide Manufacturing Capacity

CordenPharma Acquires AmbioPharm to Enhance U.S. Peptide Manufacturing Capacity

CordenPharma Acquires AmbioPharm to Enhance U.S. Peptide Manufacturing Capacity
Trendline Trendline
S Global Announces Leadership Change as Saugata Saha Departs, Impacting Market Intelligence and Data Strategy

S Global Announces Leadership Change as Saugata Saha Departs, Impacting Market Intelligence and Data Strategy

S Global Announces Leadership Change as Saugata Saha Departs, Impacting Market Intelligence and Data Strategy
Trendline Trendline
Eli Lilly Leads Pharmaceutical Innovation and Invention, Boosting Earnings and Pipeline

Eli Lilly Leads Pharmaceutical Innovation and Invention, Boosting Earnings and Pipeline

Eli Lilly Leads Pharmaceutical Innovation and Invention, Boosting Earnings and Pipeline
Trendline Trendline
Eli Lilly Advances Gene Therapy for Cholesterol Reduction with VERVE-102

Eli Lilly Advances Gene Therapy for Cholesterol Reduction with VERVE-102

Eli Lilly Advances Gene Therapy for Cholesterol Reduction with VERVE-102